The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Induction chemotherapy with and without erlotinib in patients with oral cavity squamous cell carcinomas (OCSCCs) amenable for surgical resection.
 
Xiuning Le
Consulting or Advisory Role - AstraZeneca; Lilly
 
Curtis R. Pickering
No Relationships to Disclose
 
M. Laura Rubin
No Relationships to Disclose
 
Frederico Netto
No Relationships to Disclose
 
Merrill S. Kies
No Relationships to Disclose
 
Faye M. Johnson
Honoraria - Methodist Hospital
Research Funding - PIQUR; Trovagene
 
Charles Lu
No Relationships to Disclose
 
George R. Blumenschein, Jr.
Consulting or Advisory Role - Abbvie; Adicet Bio; Amgen; ARIAD; Bayer; Bristol-Myers Squibb; Celgene; Clovis Oncology; Genentech; Merck; Novartis; Xcovery
Research Funding - Adaptimmune (Inst); Bayer Schering Pharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Exelixis; Genentech (Inst); GlaxoSmithKline (Inst); Immatics; Incyte; Kite, a Gilead company (Inst); Macrogenics (Inst); MedImmune; Merck (Inst); Novartis (Inst); Roche; Torque; Xcovery (Inst)
 
Diana Bell
No Relationships to Disclose
 
Lawrence E. Ginsberg
No Relationships to Disclose
 
Kaye F Wilson
No Relationships to Disclose
 
Jeff Lewis
No Relationships to Disclose
 
Lei Feng
No Relationships to Disclose
 
Jing Wang
No Relationships to Disclose
 
J. Jack Lee
Consulting or Advisory Role - Abbvie
 
William Nassib William
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck; Pfizer; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Merck; Pfizer; Roche
Speakers' Bureau - Boehringer Ingelheim
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck (Inst); OSI Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck
 
Jeffrey Myers
No Relationships to Disclose